Search Browse Earnings

TriSalus Life Sciences, Inc. — SlamSEC

TriSalus Life Sciences, Inc.

Nasdaq:TLSINasdaq:TLSIW

Surgical & Medical Instruments & Apparatus·WESTMINSTER, CO

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$29.4M

+59.0% YoY

FY 2025

Adj. EBITDA

-$35.4M

-120.4% margin

FY 2025

Net Income

-$30.0M

-102.1% margin

FY 2025

EPS (Diluted)

-$1.31

FY 2025

Stock Price

$4.64

-2.7%

2026-03-09

52W Range

$3.42 – $7.95

P/E Ratio

-3.5x

Market Cap

$284.5M

Cash

$8.5M

FY 2025

Total Debt

$22.1M

FY 2025

Net Debt

$13.6M

FY 2025

Enterprise Value

$298.0M

Debt / EBITDA

-0.4x

FY 2025

EV / EBITDA

-8.4x

Employees

—

CEO

Szela Mary T

CFO

Patience David